Davidson Kempner Capital Management LP

Position in HUMA — Humacyte, Inc.

CIK 1595082 New York, NY

Position in HUMA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,900,000

+$2,613,000 QoQ

Shares Held

5,000,000

+1011.1% QoQ

Ownership

1.80%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

of 161 holders

Holding Since

Jun 2023

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Davidson Kempner Capital Management LP holds $7,588,160 across 5 Biotechnology names. HUMA ranks #1 (51.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HUMA	Humacyte, Inc. This page	5,000,000	$3,900,000
2	KPTI	Karyopharm Therapeutics Inc.	300,000	$2,931,000
3	AVLN	Avalyn Pharma Inc.	23,000	$757,160
4	MLEC	Moolec Science SA	250,000	$0
5	TVGN	Tevogen Inc.	250,000	$0

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,900,000	5,000,000	+1011.1%	Shares	Sole	2026-08-14
2026-06-12	$13,490,362	12,787,073	—	Shares	Sole	2026-06-22
2023-06-30	$1,287,000	450,000	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.